Stella Sivertseva (S A Sivertseva, S A Siverzeva, S A Siverceva)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Monoclonal Antibody

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

This page only lists publications with an associated author ORCID identifier.

Publications

Stella Sivertseva, K S Anfilofeva, A V Zotova, V A Kazantsev, A Yu Belkina, L I Volkova, M E Guseva, Alexey Boyko
[The effectiveness of tele-rehabilitation for patients with multiple sclerosis during the COVID-19 pandemic in 2020-2021 was evaluated in this study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (3) (2024)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, Zh Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, A V Artemeva, Anna V Eremeeva, Yulia N Linkova, Arina V Zinkina-Orikhan
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4) (2024)
Alexey Boyko, A N Belova, Evgenia Belova, Stella Sivertseva
[Questionnaires for arm function assessment in patients with multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (6) (2024)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, Zh Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, A V Artemeva, Anna V Eremeeva, Yulia N Linkova, Arina V Zinkina-Orikhan
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4) (2024)
Stella Sivertseva, N Yu Lasch, A V Zotova, A M Sivertseva, E R Titkova, Alexey Boyko
[A role of cerebrovascular diseases in the progression of multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (5) (2024)
Alexey Boyko, K Z Bakhtiyarova, O V Boyko, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, F A Khabirov, Zoya A Goncharova, Maria Zakharova, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya, A A Porozova
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (2) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, Zh Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, D D Bolsun, Anna V Eremeeva, Yulia N Linkova, Arina V Zinkina-Orikhan
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (7. Vyp. 2) (2023)
Alexey Boyko, K Z Bakhtiyarova, O V Boyko, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, F A Khabirov, Zoya A Goncharova, Maria Zakharova, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya, A A Porozova
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (2) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
Stella Sivertseva, A M Prilenskaya, E V Popova, E L Turova, L I Volkova, I V Smagina, E Yu Elchaninova, A I Afanas'eva, Zoya A Goncharova, E A Markova, N M Yarosh, K Z Bakhtiyarova, M A Sherman, Alexey Boyko
[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (9) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
Alexey Boyko, O V Boyko, K Z Bakhtiyarova, E I Gusev, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, A S Fedulov, F A Khabirov, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya
[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (1) (2022)
D S Korobko, M A Barabanova, K Z Bakhtiyarova, N A Malkova, Stella Sivertseva, A A Sokolova, N V Khachanova
[Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (7. Vyp. 2) (2022)
N N Spirin, Ya V Vlasov, Maria Zakharova, N V Khachanova, E V Popova, F A Khabirov, N A Totolyan, Stella Sivertseva, Zoya A Goncharova, L L Korsunskaya, T I Yakushina, O V Matveevskaya, T O Simaniv, Alexey Boyko
[New opportunities in the treatment of patients with multiple sclerosis (Resolution of the Council of Experts on April 23, 2022, Moscow, JSC «BIOCAD»)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (7. Vyp. 2) (2022)
Stella Sivertseva, K S Anfilofeva, A V Zotova, M A Sherman, M E Guseva, Alexey Boyko
[Dance therapy in the rehabilitation of neurological diseases]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (7. Vyp. 2) (2022)
Stella Sivertseva, A A Belkin, A V Zotova, N S Korneeva, M E Guseva
[Preliminary results of rehabilitation intervention for the correction of cognitive impairment in patients with multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (7. Vyp. 2) (2021)
Alexey Boyko, Stella Sivertseva, D S Chemakina, N N Spirin, O V Bykova, M E Guseva
[Vaccination and multiple sclerosis at the present stage]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (7. Vyp. 2) (2021)
M E Guseva, O V Matveevskaya, Stella Sivertseva, O V Boyko
[Possibilities of art therapy and color therapy in the rehabilitation of multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (7. Vyp. 2) (2021)
Stella Sivertseva, A A Belkin, L B Artem'eva, M E Guseva
[The use of music therapy in the treatment of adverse effects in patients with multiple sclerosis treated with alemtuzumab]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (7. Vyp. 2) (2020)
N V Khachanova, K Z Bakhtiyarova, Alexey Boyko, Ya V Vlasov, M V Davydovskaya, Evgeniy Evdoshenko, Maria Zakharova, S V Kotov, E V Popova, Stella Sivertseva, N A Totolyan, F A Khabirov
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (3) (2020)
E I Gusev, Mikhail Yu Martynov, Alexey Boyko, I A Voznjouk, N Yu Lasch, Stella Sivertseva, N N Spirin, N A Shamalov
[Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (6) (2020)
Evgeniy Evdoshenko, Alexandra Stepanova, Maria Shumilina, Maria Davydovskaya, Natalia Khachanova, Nikolay Neofidov, Ivan Kalinin, Ekaterina Popova, Ekaterina Dubchenko, Natalia Pozhidaeva, Andrey Volkov, Stella Sivertseva, Anna Prilenskaya, Nadezhda Malkova, Denis Korobko, Ilona Vergunova, Sergey Shchur, Gleb Makshakov
Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia. PloS one 14 (5) (2019)